Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSyncona Regulatory News (SYNC)

Share Price Information for Syncona (SYNC)

Share Price is delayed by 15 minutes
Get Live Data
98.00    0.10 (0.10%)
Bid:
97.10
Ask:
98.20
Spread: 1.10 (1.133%)
Market Cap: £596.03m
SYNC Live PriceLast checked at - London Stock Exchange

Intraday Syncona Share Chart

Director Changes

18 Mar 2016 16:59

BACIT LIMITED - Director Changes

BACIT LIMITED - Director Changes

PR Newswire

London, March 18

BACIT Limited (the "Company")

(a closed-ended collective investment scheme established as a company with limited liability under the laws of Guernsey with registered number 55514)

Director Resignation

18 March 2016

The Company announces the resignation of Martin Thomas as a non-executive director of the Company, effective 18 March 2016.

Mr Thomas is chairman of the board of directors of BACIT (UK) Limited, the FCA regulated firm that manages the assets of BACIT Limited. Jeremy Tigue, chairman of BACIT Limited said "Martin has been instrumental in establishing BACIT (UK) Limited having been part of the team that founded BACIT in 2012. His contribution as a director of the fund has been much appreciated, and we look forward to continue working with him as chair of our appointed fund manager in the years to come”.

Company website: www.bacitltd.com

Enquiries:Northern Trust International Fund Administration Services (Guernsey) LimitedEmail: rb235@ntrs.comTel: +44 (0) 1481 745189

Date   Source Headline
9th Jan 20257:00 amRNSTransaction in Own Shares
8th Jan 20257:00 amRNSTransaction in Own Shares
7th Jan 20257:00 amRNSTransaction in Own Shares
6th Jan 20257:00 amRNSTransaction in Own Shares
3rd Jan 20257:00 amRNSTransaction in Own Shares
2nd Jan 20252:44 pmRNSTotal Voting Rights
2nd Jan 20257:00 amRNSTransaction in Own Shares
31st Dec 20247:00 amRNSTransaction in Own Shares
30th Dec 20247:00 amRNSTransaction in Own Shares
27th Dec 20247:00 amRNSAchilles announces sale of technology assets
27th Dec 20247:00 amRNSTransaction in Own Shares
24th Dec 20247:00 amRNSTransaction in Own Shares
23rd Dec 20247:00 amRNSTransaction in Own Shares
20th Dec 20247:00 amRNSTransaction in Own Shares
19th Dec 20247:00 amRNSTransaction in Own Shares
18th Dec 20247:00 amRNSTransaction in Own Shares
17th Dec 20247:00 amRNSTransaction in Own Shares
16th Dec 20247:00 amRNSTransaction in Own Shares
13th Dec 20247:00 amRNSTransaction in Own Shares
12th Dec 20247:00 amRNSTransaction in Own Shares
11th Dec 202410:35 amRNSiOnctura presents clinical data update
11th Dec 20247:00 amRNSTransaction in Own Shares
10th Dec 20247:00 amRNSTransaction in Own Shares
9th Dec 20247:00 amRNSTransaction in Own Shares
6th Dec 202412:05 pmRNSBeacon announces clinical data update
6th Dec 20247:00 amRNSTransaction in Own Shares
5th Dec 20247:00 amRNSTransaction in Own Shares
4th Dec 20247:00 amRNSTransaction in Own Shares
3rd Dec 20247:00 amRNSTransaction in Own Shares
2nd Dec 20249:43 amRNSTotal Voting Rights
2nd Dec 20247:00 amRNSTransaction in Own Shares
29th Nov 20247:00 amRNSTransaction in Own Shares
28th Nov 20247:00 amRNSTransaction in Own Shares
27th Nov 20247:00 amRNSTransaction in Own Shares
26th Nov 20247:00 amRNSTransaction in Own Shares
25th Nov 20247:00 amRNSTransaction in Own Shares
22nd Nov 20247:00 amRNSTransaction in Own Shares
21st Nov 20247:00 amRNSTransaction in Own Shares
20th Nov 20247:00 amRNSTransaction in Own Shares
19th Nov 20247:59 amRNSBoard Committee Change
19th Nov 20247:00 amRNSTransaction in Own Shares
18th Nov 20247:00 amRNSTransaction in Own Shares
15th Nov 20247:00 amRNSTransaction in Own Shares
14th Nov 20247:00 amRNSSyncona launches Slingshot Therapeutics
14th Nov 20247:00 amRNSHalf-year Report
14th Nov 20247:00 amRNSTransaction in Own Shares
13th Nov 20247:00 amRNSTransaction in Own Shares
12th Nov 20241:18 pmRNSAutolus reports Q3 2024 Financial Results
12th Nov 20247:00 amRNSTransaction in Own Shares
11th Nov 20247:00 amRNSAutolus receives US FDA approval

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.